Matinas Biopharma Holdings Inc (MTNB)

[cars100cars]

2 products now in FDA approval process. Safety profile looking good. Early efficacy numbers should come in about six months from now. FDA fast track designation adds promise to this company. If MTNB's drug platform Phase I and II data start to provide the alternative answer to outdated antibiotics, we should see this stock surge. Possibly a hot takeover target in a matter of months. Big pharma would want to control this promising drug platform. Worth it to wait and see.